when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked · 8,127 matching

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health

Marketed
Ketalar
Ketalar (ketamine hydrochloride)
General Anesthetic Effect Par Pharmaceutical Inc3 cat
Marketed
LOPERAMIDE HYDROCHLORIDE
LOPERAMIDE HYDROCHLORIDE
Diarrhea LNK International Inc (Inactive)3 cat
Marketed
NEOSTIGMINE METHYLSULFATE
NEOSTIGMINE METHYLSULFATE
no indication$AMPH Amphastar Pharmaceuticals, Inc.3 cat

page 14 of 271

131

Marketed

OSENVELT (DENOSUMAB-BMWO)

no indication

Celltrion Inc

3 cat

Marketed

Female Infertility IBSA Institut Biochimique SA3 cat

Marketed

PRUCALOPRIDE SUCCINATE

PRUCALOPRIDE SUCCINATE

Constipation SpecGx LLC3 cat

Marketed

ROCURONIUM BROMIDE

ROCURONIUM BROMIDE

Muscle Relaxation Piramal Critical Care Inc3 cat

Marketed

SITAGLIPTIN PHOSPHATE

SITAGLIPTIN PHOSPHATE

Type 2 Diabetes Merck Sharp & Dohme LLC3 cat

Marketed

no indication$AMRX Amneal Pharmaceuticals, Inc.3 cat

Marketed

SODIUM BICARBONATE

SODIUM BICARBONATE

no indication$AMRX Amneal Pharmaceuticals, Inc.3 cat

Marketed

SODIUM PHENYLBUTYRATE

SODIUM PHENYLBUTYRATE

Carbamoyl-Phosphate Synthase I Deficiency Horizon Therapeutics USA Inc3 cat

Marketed

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) RK Pharma Inc3 cat

Marketed

VARENICLINE TARTRATE

VARENICLINE TARTRATE

Keratoconjunctivitis Sicca (Dry Eye) Oyster Point Pharma Inc3 cat

no indication Jiangsu Hengrui Pharmaceuticals Co Ltd3 cat

Marketed

aflibercept biosimilar

Ahzantive (aflibercept-abzv)

Diabetic Macular Edema Sam Chun Dang Pharm Co Ltd3 cat

Marketed

avacincaptad pegol sodium

Izervay (avacincaptad pegol sodium)

Geographic Atrophy Astellas Pharma US Inc3 cat

Marketed

Colon Cancer Armas Pharmaceuticals Inc3 cat

Marketed

cyclophosphamide

Cyclophosphamide (cyclophosphamide [INN])

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Long Grove Pharmaceuticals LLC3 cat

Marketed

dalfampridine ER

Dalfampridine Mylan (dalfampridine)

Hypokinesia Mylan Pharmaceuticals Inc3 cat

Marketed

ensartinib hydrochloride

Ensacove (ensartinib hydrochloride)

Non-Small Cell Lung Cancer Xcovery Holdings Inc3 cat

Marketed

Evkeeza (evinacumab-dgnb)

Homozygous Familial Hypercholesterolemia (HoFH)$REGN REGENERON PHARMACEUTICALS, INC.3 cat

Marketed

Lytgobi (futibatinib)

Bile Duct Cancer (Cholangiocarcinoma) Taiho Oncology Inc3 cat

Marketed

Columvi (glofitamab-gxbm)

Mantle Cell Lymphoma F. Hoffmann-La Roche Ltd3 cat

Marketed

Sustol (granisetron)

Chemotherapy Induced Nausea and Vomiting Heron Therapeutics Inc3 cat

Marketed

Itovebi (inavolisib)

Human Epidermal Growth Factor Receptor 2 Positive Breast… F. Hoffmann-La Roche Ltd3 cat

Marketed

lazertinib mesylate

Lazcluze (lazertinib mesylate)

Non-Small Cell Lung Cancer$JNJ JOHNSON & JOHNSON3 cat

Marketed

Ebglyss (lebrikizumab)

Atopic Dermatitis (Atopic Eczema) Lilly USA LLC3 cat

levobupivacaine

no indication Swami Dayanand Hospital3 cat

Marketed

Hympavzi (marstacimab-hncq)

Hemophilia A (Factor VIII Deficiency)$PFE PFIZER INC3 cat

Marketed

Myrbetriq (mirabegron)

Neurogenic Bladder Dysfunction Astellas Pharma US Inc3 cat